Boston Scientific CorporationBSXNYSE
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-7.4%
5Y CAGR+6.7%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
-7.4%/yr
vs -32.8%/yr prior
5Y CAGR
+6.7%/yr
Recent deceleration
Acceleration
+25.3pp
Accelerating
Percentile
P74
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.09% |
| Q3 2025 | 0.16% |
| Q2 2025 | 2.72% |
| Q1 2025 | 5.03% |
| Q4 2024 | -0.99% |
| Q3 2024 | 2.94% |
| Q2 2024 | -0.59% |
| Q1 2024 | 15.90% |
| Q4 2023 | 2.08% |
| Q3 2023 | -1.64% |
| Q2 2023 | 0.95% |
| Q1 2023 | 0.89% |
| Q4 2022 | 3.90% |
| Q3 2022 | -4.21% |
| Q2 2022 | -3.68% |
| Q1 2022 | 2.45% |
| Q4 2021 | -0.08% |
| Q3 2021 | -0.05% |
| Q2 2021 | 0.22% |
| Q1 2021 | -1.01% |
| Q4 2020 | 2.23% |
| Q3 2020 | -4.68% |
| Q2 2020 | -7.62% |
| Q1 2020 | 3.11% |
| Q4 2019 | -5.48% |
| Q3 2019 | 14.15% |
| Q2 2019 | 3.40% |
| Q1 2019 | 31.04% |
| Q4 2018 | 6.55% |
| Q3 2018 | 2.12% |
| Q2 2018 | 12.76% |
| Q1 2018 | 2.72% |
| Q4 2017 | -1.83% |
| Q3 2017 | -2.62% |
| Q2 2017 | 5.82% |
| Q1 2017 | 0.55% |
| Q4 2016 | 1.09% |
| Q3 2016 | -0.04% |
| Q2 2016 | -4.40% |
| Q1 2016 | 0.00% |